| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CRESCENT BIOPHARMA, INC. | Chief Medical Officer | Ordinary Shares | 21,298 | $321,173 | $15.08 | 15 Dec 2025 | Direct |
| CRESCENT BIOPHARMA, INC. | Chief Medical Officer | Stock Option (Right to Buy) | 65,190 | 15 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLYC | CRESCENT BIOPHARMA, INC. | 15 Dec 2025 | 3 | $0 | 4 | Chief Medical Officer | 17 Dec 2025, 16:41 |
| GLYC | CRESCENT BIOPHARMA, INC. | 13 Jun 2025 | 0 | $0 | 3 | Chief Medical Officer | 30 Jun 2025, 16:21 |